Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study

Identifieur interne : 000549 ( Istex/Corpus ); précédent : 000548; suivant : 000550

Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study

Auteurs : E. Cuquemelle ; F. Soulis ; D. Villers ; F. Roche-Campo ; C. Ara Somohano ; M. Fartoukh ; A. Kouatchet ; B. Mourvillier ; J. Dellamonica ; W. Picard ; M. Schmidt ; T. Boulain ; C. Brun-Buisson

Source :

RBID : ISTEX:AFE1C4D3A173615DDDB9DECF2E2EDF7694B27BAB

Abstract

Abstract: Purpose: To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic. Methods: A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection. Results: Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37–56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31%). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25–75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9–45.3) versus 0.5 (0.12–2) μg/l (P < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2–51.5; P < 0.001). Conclusions: PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.

Url:
DOI: 10.1007/s00134-011-2189-1

Links to Exploration step

ISTEX:AFE1C4D3A173615DDDB9DECF2E2EDF7694B27BAB

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
<author>
<name sortKey="Cuquemelle, E" sort="Cuquemelle, E" uniqKey="Cuquemelle E" first="E." last="Cuquemelle">E. Cuquemelle</name>
<affiliation>
<mods:affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Université Paris-Est Créteil, Créteil, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Soulis, F" sort="Soulis, F" uniqKey="Soulis F" first="F." last="Soulis">F. Soulis</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Charles Nicolle, Rouen, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Villers, D" sort="Villers, D" uniqKey="Villers D" first="D." last="Villers">D. Villers</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Hotel-Dieu, Nantes, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Roche Campo, F" sort="Roche Campo, F" uniqKey="Roche Campo F" first="F." last="Roche-Campo">F. Roche-Campo</name>
<affiliation>
<mods:affiliation>Polyvalent Intensive Care Unit, Hospital Santa Creu I Sant Pau, Barcelona, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ara Somohano, C" sort="Ara Somohano, C" uniqKey="Ara Somohano C" first="C." last="Ara Somohano">C. Ara Somohano</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire A. Michallon, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fartoukh, M" sort="Fartoukh, M" uniqKey="Fartoukh M" first="M." last="Fartoukh">M. Fartoukh</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Tenon, AP-HP, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kouatchet, A" sort="Kouatchet, A" uniqKey="Kouatchet A" first="A." last="Kouatchet">A. Kouatchet</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire, Angers, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mourvillier, B" sort="Mourvillier, B" uniqKey="Mourvillier B" first="B." last="Mourvillier">B. Mourvillier</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dellamonica, J" sort="Dellamonica, J" uniqKey="Dellamonica J" first="J." last="Dellamonica">J. Dellamonica</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Archet 1, Nice, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Picard, W" sort="Picard, W" uniqKey="Picard W" first="W." last="Picard">W. Picard</name>
<affiliation>
<mods:affiliation>Polyvalent Intensive Care Unit, Centre Hospitalier F. Mitterand, Pau, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Schmidt, M" sort="Schmidt, M" uniqKey="Schmidt M" first="M." last="Schmidt">M. Schmidt</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Boulain, T" sort="Boulain, T" uniqKey="Boulain T" first="T." last="Boulain">T. Boulain</name>
<affiliation>
<mods:affiliation>Medical ICU, Centre Hospitalier Régional, Orléans, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brun Buisson, C" sort="Brun Buisson, C" uniqKey="Brun Buisson C" first="C." last="Brun-Buisson">C. Brun-Buisson</name>
<affiliation>
<mods:affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Université Paris-Est Créteil, Créteil, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: christian.brun-buisson@hmn.aphp.fr</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AFE1C4D3A173615DDDB9DECF2E2EDF7694B27BAB</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1007/s00134-011-2189-1</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-P7CR3SK6-2/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000549</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000549</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
<author>
<name sortKey="Cuquemelle, E" sort="Cuquemelle, E" uniqKey="Cuquemelle E" first="E." last="Cuquemelle">E. Cuquemelle</name>
<affiliation>
<mods:affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Université Paris-Est Créteil, Créteil, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Soulis, F" sort="Soulis, F" uniqKey="Soulis F" first="F." last="Soulis">F. Soulis</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Charles Nicolle, Rouen, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Villers, D" sort="Villers, D" uniqKey="Villers D" first="D." last="Villers">D. Villers</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Hotel-Dieu, Nantes, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Roche Campo, F" sort="Roche Campo, F" uniqKey="Roche Campo F" first="F." last="Roche-Campo">F. Roche-Campo</name>
<affiliation>
<mods:affiliation>Polyvalent Intensive Care Unit, Hospital Santa Creu I Sant Pau, Barcelona, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ara Somohano, C" sort="Ara Somohano, C" uniqKey="Ara Somohano C" first="C." last="Ara Somohano">C. Ara Somohano</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire A. Michallon, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fartoukh, M" sort="Fartoukh, M" uniqKey="Fartoukh M" first="M." last="Fartoukh">M. Fartoukh</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Tenon, AP-HP, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kouatchet, A" sort="Kouatchet, A" uniqKey="Kouatchet A" first="A." last="Kouatchet">A. Kouatchet</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire, Angers, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mourvillier, B" sort="Mourvillier, B" uniqKey="Mourvillier B" first="B." last="Mourvillier">B. Mourvillier</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dellamonica, J" sort="Dellamonica, J" uniqKey="Dellamonica J" first="J." last="Dellamonica">J. Dellamonica</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Archet 1, Nice, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Picard, W" sort="Picard, W" uniqKey="Picard W" first="W." last="Picard">W. Picard</name>
<affiliation>
<mods:affiliation>Polyvalent Intensive Care Unit, Centre Hospitalier F. Mitterand, Pau, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Schmidt, M" sort="Schmidt, M" uniqKey="Schmidt M" first="M." last="Schmidt">M. Schmidt</name>
<affiliation>
<mods:affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Boulain, T" sort="Boulain, T" uniqKey="Boulain T" first="T." last="Boulain">T. Boulain</name>
<affiliation>
<mods:affiliation>Medical ICU, Centre Hospitalier Régional, Orléans, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brun Buisson, C" sort="Brun Buisson, C" uniqKey="Brun Buisson C" first="C." last="Brun-Buisson">C. Brun-Buisson</name>
<affiliation>
<mods:affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Université Paris-Est Créteil, Créteil, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: christian.brun-buisson@hmn.aphp.fr</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Intensive Care Medicine</title>
<title level="j" type="abbrev">Intensive Care Med</title>
<idno type="ISSN">0342-4642</idno>
<idno type="eISSN">1432-1238</idno>
<imprint>
<publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-SWLMH5L1-1">Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="2011">2011</date>
<biblScope unit="vol" from="37" to="37">37</biblScope>
<biblScope unit="issue" from="5" to="5">5</biblScope>
<biblScope unit="page" from="796">796</biblScope>
<biblScope unit="page" to="800">800</biblScope>
</imprint>
<idno type="ISSN">0342-4642</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0342-4642</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Purpose: To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic. Methods: A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection. Results: Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37–56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31%). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25–75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9–45.3) versus 0.5 (0.12–2) μg/l (P < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2–51.5; P < 0.001). Conclusions: PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.</div>
</front>
</TEI>
<istex>
<corpusName>springer-journals</corpusName>
<author>
<json:item>
<name>E. Cuquemelle</name>
<affiliations>
<json:string>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Université Paris-Est Créteil, Créteil, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>F. Soulis</name>
<affiliations>
<json:string>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Charles Nicolle, Rouen, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>D. Villers</name>
<affiliations>
<json:string>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Hotel-Dieu, Nantes, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>F. Roche-Campo</name>
<affiliations>
<json:string>Polyvalent Intensive Care Unit, Hospital Santa Creu I Sant Pau, Barcelona, Spain</json:string>
</affiliations>
</json:item>
<json:item>
<name>C. Ara Somohano</name>
<affiliations>
<json:string>Medical Intensive Care Unit, Centre Hospitalo-Universitaire A. Michallon, Grenoble, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>M. Fartoukh</name>
<affiliations>
<json:string>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Tenon, AP-HP, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>A. Kouatchet</name>
<affiliations>
<json:string>Medical Intensive Care Unit, Centre Hospitalo-Universitaire, Angers, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>B. Mourvillier</name>
<affiliations>
<json:string>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>J. Dellamonica</name>
<affiliations>
<json:string>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Archet 1, Nice, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>W. Picard</name>
<affiliations>
<json:string>Polyvalent Intensive Care Unit, Centre Hospitalier F. Mitterand, Pau, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>M. Schmidt</name>
<affiliations>
<json:string>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>T. Boulain</name>
<affiliations>
<json:string>Medical ICU, Centre Hospitalier Régional, Orléans, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>C. Brun-Buisson</name>
<affiliations>
<json:string>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Université Paris-Est Créteil, Créteil, France</json:string>
<json:string>E-mail: christian.brun-buisson@hmn.aphp.fr</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Procalcitonin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Pneumonia</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>A/H1N1v influenza</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Bacterial infection</value>
</json:item>
</subject>
<articleId>
<json:string>2189</json:string>
<json:string>s00134-011-2189-1</json:string>
</articleId>
<arkIstex>ark:/67375/VQC-P7CR3SK6-2</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>OriginalPaper</json:string>
</originalGenre>
<abstract>Abstract: Purpose: To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic. Methods: A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection. Results: Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37–56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31%). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25–75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9–45.3) versus 0.5 (0.12–2) μg/l (P > 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2–51.5; P > 0.001). Conclusions: PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.</abstract>
<qualityIndicators>
<score>5.55</score>
<pdfWordCount>2874</pdfWordCount>
<pdfCharCount>19537</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>5</pdfPageCount>
<pdfPageSize>595.276 x 790.866 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractWordCount>223</abstractWordCount>
<abstractCharCount>1537</abstractCharCount>
<keywordCount>4</keywordCount>
<pdfWordsPerPage>575</pdfWordsPerPage>
<pdfText>true</pdfText>
</qualityIndicators>
<title>Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
<corporate>
<json:item>
<name>A/H1N1 REVA-SRLF Study Group</name>
</json:item>
</corporate>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<title>Intensive Care Medicine</title>
<language>
<json:string>unknown</json:string>
</language>
<publicationDate>2011</publicationDate>
<copyrightDate>2011</copyrightDate>
<issn>
<json:string>0342-4642</json:string>
</issn>
<eissn>
<json:string>1432-1238</json:string>
</eissn>
<journalId>
<json:string>134</json:string>
</journalId>
<volume>37</volume>
<issue>5</issue>
<pages>
<first>796</first>
<last>800</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Pain Medicine</value>
</json:item>
<json:item>
<value>Anesthesiology</value>
</json:item>
<json:item>
<value>Pneumology/Respiratory System</value>
</json:item>
<json:item>
<value>Pediatrics</value>
</json:item>
<json:item>
<value>Emergency Medicine</value>
</json:item>
<json:item>
<value>Intensive / Critical Care Medicine</value>
</json:item>
</subject>
</host>
<ark>
<json:string>ark:/67375/VQC-P7CR3SK6-2</json:string>
</ark>
<publicationDate>2011</publicationDate>
<copyrightDate>2011</copyrightDate>
<doi>
<json:string>10.1007/s00134-011-2189-1</json:string>
</doi>
<id>AFE1C4D3A173615DDDB9DECF2E2EDF7694B27BAB</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-P7CR3SK6-2/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-P7CR3SK6-2/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/VQC-P7CR3SK6-2/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-SWLMH5L1-1">Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<availability>
<licence>Copyright jointly held by Springer and ESICM</licence>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</p>
</availability>
<date type="published" when="2011">2011</date>
</publicationStmt>
<notesStmt>
<note type="content-type" subtype="research-article" source="OriginalPaper" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-5WTPMB5N-F">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
<author>
<persName>
<forename type="first">E.</forename>
<surname>Cuquemelle</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP</orgName>
<orgName type="institution">Université Paris-Est Créteil</orgName>
<address>
<settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">F.</forename>
<surname>Soulis</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical Intensive Care Unit</orgName>
<orgName type="institution">Centre Hospitalo-Universitaire Charles Nicolle</orgName>
<address>
<settlement>Rouen</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">D.</forename>
<surname>Villers</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical Intensive Care Unit</orgName>
<orgName type="institution">Centre Hospitalo-Universitaire Hotel-Dieu</orgName>
<address>
<settlement>Nantes</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">F.</forename>
<surname>Roche-Campo</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Polyvalent Intensive Care Unit</orgName>
<orgName type="institution">Hospital Santa Creu I Sant Pau</orgName>
<address>
<settlement>Barcelona</settlement>
<country key="ES" xml:lang="en">SPAIN</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">C.</forename>
<surname>Ara Somohano</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical Intensive Care Unit</orgName>
<orgName type="institution">Centre Hospitalo-Universitaire A. Michallon</orgName>
<address>
<settlement>Grenoble</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">M.</forename>
<surname>Fartoukh</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical Intensive Care Unit</orgName>
<orgName type="institution">APHP, Centre Hospitalo-Universitaire Tenon, AP-HP</orgName>
<address>
<settlement>Paris</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">A.</forename>
<surname>Kouatchet</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical Intensive Care Unit</orgName>
<orgName type="institution">Centre Hospitalo-Universitaire</orgName>
<address>
<settlement>Angers</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">B.</forename>
<surname>Mourvillier</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical Intensive Care Unit</orgName>
<orgName type="institution">APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP</orgName>
<address>
<settlement>Paris</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">J.</forename>
<surname>Dellamonica</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical Intensive Care Unit</orgName>
<orgName type="institution">Centre Hospitalo-Universitaire Archet 1</orgName>
<address>
<settlement>Nice</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">W.</forename>
<surname>Picard</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Polyvalent Intensive Care Unit</orgName>
<orgName type="institution">Centre Hospitalier F. Mitterand</orgName>
<address>
<settlement>Pau</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">M.</forename>
<surname>Schmidt</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical Intensive Care Unit</orgName>
<orgName type="institution">APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP</orgName>
<address>
<settlement>Paris</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<persName>
<forename type="first">T.</forename>
<surname>Boulain</surname>
</persName>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Medical ICU</orgName>
<orgName type="institution">Centre Hospitalier Régional</orgName>
<address>
<settlement>Orléans</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author role="corresp">
<persName>
<forename type="first">C.</forename>
<surname>Brun-Buisson</surname>
</persName>
<email>christian.brun-buisson@hmn.aphp.fr</email>
<affiliation>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<orgName type="department">Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP</orgName>
<orgName type="institution">Université Paris-Est Créteil</orgName>
<address>
<settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author>
<orgName type="institution">A/H1N1 REVA-SRLF Study Group</orgName>
<persName>
<surname>A/H1N1 REVA-SRLF Study Group</surname>
</persName>
</author>
<idno type="istex">AFE1C4D3A173615DDDB9DECF2E2EDF7694B27BAB</idno>
<idno type="ark">ark:/67375/VQC-P7CR3SK6-2</idno>
<idno type="publisher-id">s00134-011-2189-1</idno>
<idno type="DOI">10.1007/s00134-011-2189-1</idno>
<idno type="article-id">2189</idno>
</analytic>
<monogr>
<title level="j" type="main">Intensive Care Medicine</title>
<title level="j" type="abbrev">Intensive Care Med</title>
<idno type="journal-id">134</idno>
<idno type="pISSN">0342-4642</idno>
<idno type="eISSN">1432-1238</idno>
<imprint>
<publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-SWLMH5L1-1">Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="2011">2011</date>
<biblScope unit="vol" from="37" to="37">37</biblScope>
<biblScope unit="issue" from="5" to="5">5</biblScope>
<biblScope unit="page" from="796">796</biblScope>
<biblScope unit="page" to="800">800</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc>
<schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo>
<application ident="pub2tei" version="1.0.48" when="2020-05-28">
<label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc>
<abstract xml:lang="en">
<head>Abstract</head>
<head>Purpose</head>
<p>To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic.</p>
<head>Methods</head>
<p>A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection.</p>
<head>Results</head>
<p>Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37–56%) had a documented bacterial co-infection, mostly caused by
<hi rend="italic">Streptococcus pneumoniae</hi>
(54%) or
<hi rend="italic">Staphylococcus aureus</hi>
(31%). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25–75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9–45.3) versus 0.5 (0.12–2) μg/l (
<hi rend="italic">P</hi>
 < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2–51.5;
<hi rend="italic">P</hi>
 < 0.001).</p>
<head>Conclusions</head>
<p>PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.</p>
</abstract>
<textClass ana="subject">
<keywords scheme="journal-subject">
<list>
<item>
<term type="Primary">Medicine & Public Health</term>
</item>
<item>
<term type="Secondary">Pain Medicine</term>
</item>
<item>
<term type="Secondary">Anesthesiology</term>
</item>
<item>
<term type="Secondary">Pneumology/Respiratory System</term>
</item>
<item>
<term type="Secondary">Pediatrics</term>
</item>
<item>
<term type="Secondary">Emergency Medicine</term>
</item>
<item>
<term type="Secondary">Intensive / Critical Care Medicine</term>
</item>
</list>
</keywords>
</textClass>
<textClass ana="keyword">
<keywords xml:lang="en">
<term>Procalcitonin</term>
<term>Pneumonia</term>
<term>A/H1N1v influenza</term>
<term>Bacterial infection</term>
</keywords>
</textClass>
<langUsage>
<language ident="en"></language>
</langUsage>
</profileDesc>
<revisionDesc>
<change when="2020-05-28" who="#istex" xml:id="pub2tei">formatting</change>
<change when="2011-02-15">Registration</change>
<change when="2010-11-21">Received</change>
<change when="2010-11-27">Accepted</change>
<change when="2011-03-03">ePublished</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-P7CR3SK6-2/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus springer-journals not found" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType>
<istex:document>
<Publisher>
<PublisherInfo>
<PublisherName>Springer-Verlag</PublisherName>
<PublisherLocation>Berlin/Heidelberg</PublisherLocation>
</PublisherInfo>
<Journal OutputMedium="All">
<JournalInfo JournalProductType="NonStandardArchiveJournal" NumberingStyle="Unnumbered">
<JournalID>134</JournalID>
<JournalPrintISSN>0342-4642</JournalPrintISSN>
<JournalElectronicISSN>1432-1238</JournalElectronicISSN>
<JournalTitle>Intensive Care Medicine</JournalTitle>
<JournalAbbreviatedTitle>Intensive Care Med</JournalAbbreviatedTitle>
<JournalSubjectGroup>
<JournalSubject Type="Primary">Medicine & Public Health</JournalSubject>
<JournalSubject Type="Secondary">Pain Medicine</JournalSubject>
<JournalSubject Type="Secondary">Anesthesiology</JournalSubject>
<JournalSubject Type="Secondary">Pneumology/Respiratory System</JournalSubject>
<JournalSubject Type="Secondary">Pediatrics</JournalSubject>
<JournalSubject Type="Secondary">Emergency Medicine</JournalSubject>
<JournalSubject Type="Secondary">Intensive / Critical Care Medicine</JournalSubject>
</JournalSubjectGroup>
</JournalInfo>
<Volume OutputMedium="All">
<VolumeInfo TocLevels="0" VolumeType="Regular">
<VolumeIDStart>37</VolumeIDStart>
<VolumeIDEnd>37</VolumeIDEnd>
<VolumeIssueCount>12</VolumeIssueCount>
</VolumeInfo>
<Issue IssueType="Regular" OutputMedium="All">
<IssueInfo IssueType="Regular" TocLevels="0">
<IssueIDStart>5</IssueIDStart>
<IssueIDEnd>5</IssueIDEnd>
<IssueArticleCount>30</IssueArticleCount>
<IssueHistory>
<OnlineDate>
<Year>2011</Year>
<Month>4</Month>
<Day>8</Day>
</OnlineDate>
<PrintDate>
<Year>2011</Year>
<Month>4</Month>
<Day>7</Day>
</PrintDate>
<CoverDate>
<Year>2011</Year>
<Month>5</Month>
</CoverDate>
<PricelistYear>2011</PricelistYear>
</IssueHistory>
<IssueCopyright>
<CopyrightHolderName>Copyright jointly held by Springer and ESICM</CopyrightHolderName>
<CopyrightYear>2011</CopyrightYear>
</IssueCopyright>
</IssueInfo>
<Article ID="s00134-011-2189-1" OutputMedium="All">
<ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
<ArticleID>2189</ArticleID>
<ArticleDOI>10.1007/s00134-011-2189-1</ArticleDOI>
<ArticleSequenceNumber>10</ArticleSequenceNumber>
<ArticleTitle Language="En" OutputMedium="All">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</ArticleTitle>
<ArticleCategory>Original</ArticleCategory>
<ArticleFirstPage>796</ArticleFirstPage>
<ArticleLastPage>800</ArticleLastPage>
<ArticleHistory>
<RegistrationDate>
<Year>2011</Year>
<Month>2</Month>
<Day>15</Day>
</RegistrationDate>
<Received>
<Year>2010</Year>
<Month>11</Month>
<Day>21</Day>
</Received>
<Accepted>
<Year>2010</Year>
<Month>11</Month>
<Day>27</Day>
</Accepted>
<OnlineDate>
<Year>2011</Year>
<Month>3</Month>
<Day>3</Day>
</OnlineDate>
</ArticleHistory>
<ArticleCopyright>
<CopyrightHolderName>Copyright jointly held by Springer and ESICM</CopyrightHolderName>
<CopyrightYear>2011</CopyrightYear>
</ArticleCopyright>
<ArticleGrants Type="Regular">
<MetadataGrant Grant="OpenAccess"></MetadataGrant>
<AbstractGrant Grant="OpenAccess"></AbstractGrant>
<BodyPDFGrant Grant="Restricted"></BodyPDFGrant>
<BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant>
<BibliographyGrant Grant="Restricted"></BibliographyGrant>
<ESMGrant Grant="Restricted"></ESMGrant>
</ArticleGrants>
</ArticleInfo>
<ArticleHeader>
<AuthorGroup>
<Author AffiliationIDS="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>E.</GivenName>
<FamilyName>Cuquemelle</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff2">
<AuthorName DisplayOrder="Western">
<GivenName>F.</GivenName>
<FamilyName>Soulis</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff3">
<AuthorName DisplayOrder="Western">
<GivenName>D.</GivenName>
<FamilyName>Villers</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff4">
<AuthorName DisplayOrder="Western">
<GivenName>F.</GivenName>
<FamilyName>Roche-Campo</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff5">
<AuthorName DisplayOrder="Western">
<GivenName>C.</GivenName>
<FamilyName>Ara Somohano</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff6">
<AuthorName DisplayOrder="Western">
<GivenName>M.</GivenName>
<FamilyName>Fartoukh</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff7">
<AuthorName DisplayOrder="Western">
<GivenName>A.</GivenName>
<FamilyName>Kouatchet</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff8">
<AuthorName DisplayOrder="Western">
<GivenName>B.</GivenName>
<FamilyName>Mourvillier</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff9">
<AuthorName DisplayOrder="Western">
<GivenName>J.</GivenName>
<FamilyName>Dellamonica</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff10">
<AuthorName DisplayOrder="Western">
<GivenName>W.</GivenName>
<FamilyName>Picard</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff11">
<AuthorName DisplayOrder="Western">
<GivenName>M.</GivenName>
<FamilyName>Schmidt</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff12">
<AuthorName DisplayOrder="Western">
<GivenName>T.</GivenName>
<FamilyName>Boulain</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>C.</GivenName>
<FamilyName>Brun-Buisson</FamilyName>
</AuthorName>
<Contact>
<Phone>+33-1-49812391</Phone>
<Fax>+33-1-42079943</Fax>
<Email>christian.brun-buisson@hmn.aphp.fr</Email>
</Contact>
</Author>
<InstitutionalAuthor>
<InstitutionalAuthorName>A/H1N1 REVA-SRLF Study Group</InstitutionalAuthorName>
</InstitutionalAuthor>
<Affiliation ID="Aff1">
<OrgDivision>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP</OrgDivision>
<OrgName>Université Paris-Est Créteil</OrgName>
<OrgAddress>
<City>Créteil</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff2">
<OrgDivision>Medical Intensive Care Unit</OrgDivision>
<OrgName>Centre Hospitalo-Universitaire Charles Nicolle</OrgName>
<OrgAddress>
<City>Rouen</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff3">
<OrgDivision>Medical Intensive Care Unit</OrgDivision>
<OrgName>Centre Hospitalo-Universitaire Hotel-Dieu</OrgName>
<OrgAddress>
<City>Nantes</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff4">
<OrgDivision>Polyvalent Intensive Care Unit</OrgDivision>
<OrgName>Hospital Santa Creu I Sant Pau</OrgName>
<OrgAddress>
<City>Barcelona</City>
<Country Code="ES">Spain</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff5">
<OrgDivision>Medical Intensive Care Unit</OrgDivision>
<OrgName>Centre Hospitalo-Universitaire A. Michallon</OrgName>
<OrgAddress>
<City>Grenoble</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff6">
<OrgDivision>Medical Intensive Care Unit</OrgDivision>
<OrgName>APHP, Centre Hospitalo-Universitaire Tenon, AP-HP</OrgName>
<OrgAddress>
<City>Paris</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff7">
<OrgDivision>Medical Intensive Care Unit</OrgDivision>
<OrgName>Centre Hospitalo-Universitaire</OrgName>
<OrgAddress>
<City>Angers</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff8">
<OrgDivision>Medical Intensive Care Unit</OrgDivision>
<OrgName>APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP</OrgName>
<OrgAddress>
<City>Paris</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff9">
<OrgDivision>Medical Intensive Care Unit</OrgDivision>
<OrgName>Centre Hospitalo-Universitaire Archet 1</OrgName>
<OrgAddress>
<City>Nice</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff10">
<OrgDivision>Polyvalent Intensive Care Unit</OrgDivision>
<OrgName>Centre Hospitalier F. Mitterand</OrgName>
<OrgAddress>
<City>Pau</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff11">
<OrgDivision>Medical Intensive Care Unit</OrgDivision>
<OrgName>APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP</OrgName>
<OrgAddress>
<City>Paris</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff12">
<OrgDivision>Medical ICU</OrgDivision>
<OrgName>Centre Hospitalier Régional</OrgName>
<OrgAddress>
<City>Orléans</City>
<Country Code="FR">France</Country>
</OrgAddress>
</Affiliation>
</AuthorGroup>
<Abstract ID="Abs1" Language="En" OutputMedium="All">
<Heading>Abstract</Heading>
<AbstractSection ID="ASec1">
<Heading>Purpose</Heading>
<Para>To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic.</Para>
</AbstractSection>
<AbstractSection ID="ASec2">
<Heading>Methods</Heading>
<Para>A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection.</Para>
</AbstractSection>
<AbstractSection ID="ASec3">
<Heading>Results</Heading>
<Para>Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37–56%) had a documented bacterial co-infection, mostly caused by
<Emphasis Type="Italic">Streptococcus pneumoniae</Emphasis>
(54%) or
<Emphasis Type="Italic">Staphylococcus aureus</Emphasis>
(31%). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25–75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9–45.3) versus 0.5 (0.12–2) μg/l (
<Emphasis Type="Italic">P</Emphasis>
 < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2–51.5;
<Emphasis Type="Italic">P</Emphasis>
 < 0.001).</Para>
</AbstractSection>
<AbstractSection ID="ASec4">
<Heading>Conclusions</Heading>
<Para>PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.</Para>
</AbstractSection>
</Abstract>
<KeywordGroup Language="En" OutputMedium="All">
<Heading>Keywords</Heading>
<Keyword>Procalcitonin</Keyword>
<Keyword>Pneumonia</Keyword>
<Keyword>A/H1N1v influenza</Keyword>
<Keyword>Bacterial infection</Keyword>
</KeywordGroup>
<ArticleNote Type="Misc">
<SimplePara>Members of the A/H1N1 REVA-SRLF Study Group are list in the Appendix.</SimplePara>
</ArticleNote>
</ArticleHeader>
<NoBody></NoBody>
</Article>
</Issue>
</Volume>
</Journal>
</Publisher>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
</titleInfo>
<name type="corporate">
<namePart>A/H1N1 REVA-SRLF Study Group</namePart>
</name>
<name type="personal">
<namePart type="given">E.</namePart>
<namePart type="family">Cuquemelle</namePart>
<affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Université Paris-Est Créteil, Créteil, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Soulis</namePart>
<affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Charles Nicolle, Rouen, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Villers</namePart>
<affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Hotel-Dieu, Nantes, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Roche-Campo</namePart>
<affiliation>Polyvalent Intensive Care Unit, Hospital Santa Creu I Sant Pau, Barcelona, Spain</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C.</namePart>
<namePart type="family">Ara Somohano</namePart>
<affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire A. Michallon, Grenoble, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Fartoukh</namePart>
<affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Tenon, AP-HP, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Kouatchet</namePart>
<affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire, Angers, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">B.</namePart>
<namePart type="family">Mourvillier</namePart>
<affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Dellamonica</namePart>
<affiliation>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Archet 1, Nice, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">W.</namePart>
<namePart type="family">Picard</namePart>
<affiliation>Polyvalent Intensive Care Unit, Centre Hospitalier F. Mitterand, Pau, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Schmidt</namePart>
<affiliation>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">T.</namePart>
<namePart type="family">Boulain</namePart>
<affiliation>Medical ICU, Centre Hospitalier Régional, Orléans, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal" displayLabel="corresp">
<namePart type="given">C.</namePart>
<namePart type="family">Brun-Buisson</namePart>
<affiliation>Service de Réanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Université Paris-Est Créteil, Créteil, France</affiliation>
<affiliation>E-mail: christian.brun-buisson@hmn.aphp.fr</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="OriginalPaper" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo>
<publisher>Springer-Verlag</publisher>
<place>
<placeTerm type="text">Berlin/Heidelberg</placeTerm>
</place>
<dateCreated encoding="w3cdtf">2010-11-21</dateCreated>
<dateIssued encoding="w3cdtf">2011-05-01</dateIssued>
<copyrightDate encoding="w3cdtf">2011</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<abstract lang="en">Abstract: Purpose: To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic. Methods: A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection. Results: Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37–56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31%). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25–75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9–45.3) versus 0.5 (0.12–2) μg/l (P < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2–51.5; P < 0.001). Conclusions: PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.</abstract>
<note>Original</note>
<subject lang="en">
<genre>Keywords</genre>
<topic>Procalcitonin</topic>
<topic>Pneumonia</topic>
<topic>A/H1N1v influenza</topic>
<topic>Bacterial infection</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Intensive Care Medicine</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Intensive Care Med</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo>
<publisher>Springer</publisher>
<dateIssued encoding="w3cdtf">2011</dateIssued>
<copyrightDate encoding="w3cdtf">2011</copyrightDate>
</originInfo>
<subject>
<genre>Medicine & Public Health</genre>
<topic>Pain Medicine</topic>
<topic>Anesthesiology</topic>
<topic>Pneumology/Respiratory System</topic>
<topic>Pediatrics</topic>
<topic>Emergency Medicine</topic>
<topic>Intensive / Critical Care Medicine</topic>
</subject>
<identifier type="ISSN">0342-4642</identifier>
<identifier type="eISSN">1432-1238</identifier>
<identifier type="JournalID">134</identifier>
<identifier type="IssueArticleCount">30</identifier>
<identifier type="VolumeIssueCount">12</identifier>
<part>
<date>2011</date>
<detail type="volume">
<number>37</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>5</number>
<caption>no.</caption>
</detail>
<extent unit="pages">
<start>796</start>
<end>800</end>
</extent>
</part>
<recordInfo>
<recordOrigin>Copyright jointly held by Springer and ESICM, 2011</recordOrigin>
</recordInfo>
</relatedItem>
<identifier type="istex">AFE1C4D3A173615DDDB9DECF2E2EDF7694B27BAB</identifier>
<identifier type="ark">ark:/67375/VQC-P7CR3SK6-2</identifier>
<identifier type="DOI">10.1007/s00134-011-2189-1</identifier>
<identifier type="ArticleID">2189</identifier>
<identifier type="ArticleID">s00134-011-2189-1</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright jointly held by Springer and ESICM, 2011</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</recordContentSource>
<recordOrigin>Converted from (version 1.2.14) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2020-05-28</recordCreationDate>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-P7CR3SK6-2/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000549 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000549 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:AFE1C4D3A173615DDDB9DECF2E2EDF7694B27BAB
   |texte=   Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021